Publications by authors named "Richard Chaisson"

Claim this Profile
A
A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
John Z Metcalfe, Isabelle R Weir, Kimberly K Scarsi, Alberto Mendoza-Ticona, Samuel Pierre, Richard Chaisson

Lancet Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of a Home-based Approach to Child Contact Investigation and Tuberculosis Preventive Treatment Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial.
Nicole Salazar-Austin, Silvia Cohn, Bareng A S Nonyane, Christiaan Mulder, Fiseha Mulatu, Richard E Chaisson

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil.
Isadora Salles, Jamile Garcia de Oliveira, Alexandra Brito de Souza, Silvia Cohn, Renata Spener-Gomes, Richard E Chaisson

J Bras Pneumol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing multidrug resistant tuberculosis: the dawn of a new era.
Gavin J Churchyard, Susan Swindells, Amita Gupta, N Sarita Shah, Michael Hughes, Richard E Chaisson

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial.
Ethel D Weld, Trevor Beattie, Jayajothi Moodley, Manasa Mapendere, Isadora Salles, Richard E Chaisson

Lancet HIV· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis disease among people with HIV: therapeutic advances.
Vidya Mave, Mandar Paradkar, Francesca Conradie, Amita Gupta, Anchalee Avihingsanon, Richard E Chaisson

Lancet HIV· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid, Richard E Chaisson

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial.
Kate Shearer, Bareng A S Nonyane, Christiaan Mulder, Emmanuel Kaonga, Rose Nyirenda, Richard E Chaisson

BMJ Glob Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB).
Akash Malhotra, Ahmed Bedru, Fiseha Mulatu, Bareng A S Nonyane, Silvia Cohn, Richard E Chaisson

PLOS Glob Public Health· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, Patrick P J Phillips, Nigel A Scott, Richard E Chaisson

Emerg Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in tuberculosis infection and disease among people with HIV.
Lelia H Chaisson, Betina Durovni, Nasir Umar, Silvia Cohn, Lawrence H Moulton, Richard E Chaisson

AIDS· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.
Violet Chihota, Makaita Gombe, Amita Gupta, Nicole Salazar-Austin, Tess Ryckman, Richard E Chaisson

Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.
Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang, Patrick P J Phillips, Richard E Chaisson

Am J Respir Crit Care Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid, Richard E Chaisson

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With HIV in the North West Province of South Africa (the Teko Study): A Cluster Randomized Trial.
Brooke A Jarrett, Kate Shearer, Katlego Motlhaoleng, Sandy Chon, Gaolaolwe Gabriel Letuba, Richard E Chaisson

Clin Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving access to tuberculosis preventive treatment for children in Ethiopia: designing a home-based contact management intervention for the CHIP-TB trial through formative research.
Nicole Salazar-Austin, Alanna J Bergman, Christiaan Mulder, Carrie Tudor, Fiseha Mulatu, Richard E Chaisson

BMC Health Serv Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang, Richard E Chaisson

Clin Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
Kunchok Dorjee, Tenzin Namdon, Sonam Topgyal, Ugen Gyatso, Tenzin Tsundue, Richard E Chaisson

Vaccine· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester.
Amita Gupta, Michael D Hughes, Jorge Leon Cruz, Anchalee Avihingsanon, Noluthando Mwelase, Richard E Chaisson

Clin Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
Sonya Krishnan, Richard E Chaisson

Clin Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restocking the tuberculosis drug arsenal.
Eric L Nuermberger, Richard E Chaisson

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
Michael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, Alyssa Bercasio, Anurag Bhargava, Richard Chaisson

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis.
Nicholas Winters, Robert Belknap, Andrea Benedetti, Andrey Borisov, Jonathon R Campbell, Richard E Chaisson

Lancet Respir Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis.
Theresa Ryckman, Jeff Weiser, Makaita Gombe, Karin Turner, Priyanka Soni, Richard E Chaisson

Lancet Glob Health· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB).
Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, Christiaan Mulder, Piotr Hippner, Richard E Chaisson

Trials· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis